VistaGen Therapeutics, Inc. (VSTA) Sees AV-101 as Potential...

September 25, 2014 It's one of the single most sought-after drugs in the medical industry, and biotechnology company VistaGen Therapeutics may have it. What is so desperately needed is a drug able to treat a disease that afflicts tens of millions of people in the U.S., and hundreds of millions globally.

http://ift.tt/YeTyID